Merck Global Health Innovation Fund is a venture capital firm in Whitehouse Station that prefers to invest in emerging healthcare technology companies. Founded 2010 in Whitehouse Station, New Jersey, the firm invests in Series B, Series D, Series C, and Series E rounds. The notable investment portfolio of Merck Global Health Innovation Fund includes PathAI, Navigating Cancer, Ciox Health, and GenomeDx Biosciences. As of January 2020, Merck Global Health Innovation Fund has made 57 investments and 14 exits. Their most recent investment was on Nov 4, 2019, when PathAI raised $15M.
Antidote.me closes the gap between clinical trials and patients
PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.
Zapata Computing is a company developing quantum software and algorithms for business founded in 2017 by Christopher Savoie, Alán Aspuru-Guzik, Jhonathan Romero Fontalvo, Jonathan Olson, Peter Johnson and Yudong Cao.
A company offering delivery service for time-critical shipments using high-speed long-range drones
A healthcare company using artificial intelligence to help track and predict the onset of human diseases.
Syapse is a San Francisco-based company founded by Glenn Winokur, Jonathan Hirsch and Tony Loeser.
Livongo Health is an IT healthcare company developing and providing a digital platform health monitoring solution.
A diagnostics company focused on the discovery and development of diagnostic products for clinical laboratories for the management of oncology and genetic disorder.
A company that offers DNA analysis and genome mapping system
AbSci is a Vancouver, Washington-based company founded by Sean McClain.
AbSci, LLC is a company that is translating ideas into drugs.
A company offering technology-based care solutions and services for the senior care
Moffitt Genetics Corporation, Inc. is a company founded by Bill William S. Dalton.
StrataOncology is an Ann Arbor, Michigan-based company founded by Dan Rhodes.
Remedy Informatics is a Salt Lake City-based software company founded by Erik S. Oh.
A company developing biological diagnostic tests and services to prevent and manage cardiovascular diseases
A company developing treatments for prostate cancer and other urologic cancers
Navigating Cancer is a company founded by Eva Ho.
A company developing molecular diagnostic tests to identify pathogens
David M. Rubin
Francesca Domenech Wuttke
Managing Director and Head of Venture Investments
Documentaries, videos and podcasts